Skip to main content
31 March 2025
Last updated:
Sunday 30 March 2025
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Policy & Regulation
Policy & Regulation
Achieving federated analysis through partnership, by Philip Quinlan
Read more
Commentary, Real-world data should drive obesity drug use, by Femida Gwadry-Sridhar
Read more
EU guides on the use of AI in medicines regulation
Read more
GLP-1 agonist shortages set to continue
Read more
Efpia: A competitive strategy for the future
Read more
More advanced planning needed for antimicrobials
Read more
New antibiotics pass regulatory hurdles
Read more
EU prepares for expansion of biotech
Read more
FDA guidance on drugs for early Alzheimer's disease
Read more
EMA reflects on 2023
Read more
Pagination
Page 1
Next page
››
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form